Answers are grounded in this paper and cite their sources.
Purpose Epstein–Barr virus (EBV)-associated gastric cancer (EBVaGC), which is characterized by an inflamed tumor microenvironment, may represent a relevant subgroup in the setting of immune checkpoint inhibitor (ICI)-based therapy. We evaluated whether EBV positivity identifies a distinct subgroup of gastric cancer in patients receiving first-line chemoimmunotherapy and determined its association with programmed death-ligand 1 (PD-L1) expression and microsatellite instability.
No takes yet. Share an insight, caveat, or question.
조동우 et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: